Today's Vidyya examines the sexually transmitted disease, Chlamydia. Although infection rates for the disease are high, less than one third of practitioner's test their at risk populations. Last year, an easy to use test that can screen for Chlamydia trachomatis in urine was approved by the FDA. This test enables clinicians to screen for the infection without having to take a genital swab.

This Vidyya issue provides information from well-respected sources on the infection, the treatment and the testing for chlamydia. Practitioners will want to watch for new treatment and screening guidelines for the disease, which are due for release in the next few weeks.

Articles in today's Vidyya are:

• Chlamydia Screening Underused: US Rate Stands At Under 35%

• Chlamydia's Quick Cure - Fight Against Silent STD Includes Screening Test, One-Dose Drug

• Fact Sheet: Chlamydial Infection

• Azithromycin (Zithromax ®) Prescribing Information - The One Day Cure For Chlamydial Infection

• Guidelines for Treatment of Sexually Transmitted Diseases